![]() |
||||||||
LET'S LEARN TO USE THE F-WORD
Database fusion gives us a better way to target television
By Erwin Ephron
|
|
But it's hard to have big brands without big media, and that need for big media's reach in the face of TV fragmentation, has pushed advertisers towards media-mix. It is more than a flow-chart strategy. Media-mix requires combining data sources to estimate cross-media duplication and campaign reach and frequency. Television and Print top the list of databases that need to be integrated for true media-mix planning. A monumental job. Single-source
But the brass ring of media-mix information isn't data integration, it's "single source," a study accurately measuring many media and product-use in a single national sample. The single-source studies we currently use are a shadow of that promise. The glaring problem is the television recall measurement they are forced to use.
The alternative route to single-source might be to start with a meter panel, like the NTI Peoplemeter sample, and survey panel members for the added information that would make it single-source. But that is not an option. The burden of a lengthy MRI-type print, other media and product usage survey would substantially reduce already low meter panel cooperation rates, throwing into question the value of the TV data. So we're at an impasse. We don't use single-source. We measure TV with a Peoplemeter panel and measure most everything else in different surveys. To do a mixed-media plan we use random duplication or MRI cross-media duplication rates or we make things up. An alternative is data fusion. Data fusion
The fusion concept is simple. Database A is the magazine readership
survey. Database B is the TV peoplemeter panel. Database A is
'married' to Database B at the respondent level by ascribing the survey-measured
behavior of its respondents to matched peoplemeter panel members.
When this is done, the fused peoplemeter database acts as if its respondents had participated in the print survey and answered the magazine reading and product use questions. That's the theory. If this seems spooky, you're giving fusion too much credit. The NTI panel member's ascribed reading will not be the same as his or her actual reading, but in aggregate the fused database will produce the same numbers as appear in the MRI readership survey and the NTI respondent database TV viewing will be unchanged. The fusion match is usually limited to about a dozen characteristics collected by both surveys. If the ascribed behaviors used in planning are strongly associated with the links used to match respondents, the fusion will "work." [1] In some cases, such as product categories where lifestyles rather than demography determine usage, the fusion "hooks" will not be as relevant and the fused data will not be as good. But that usual question "how good is a fusion?" is the wrong question. We should be asking "is using fusion better than what we are currently doing?" Fusion works on the same statistical assumptions as when we target Women 18-49 for shampoo commercials because, per-capita, that group uses more shampoo. But the fusion match, ascribing shampoo use to TV viewers is likely to be better because it uses more variables. The MARS/NTI fusion
It is a special purpose database. The MARS Pharmaceutical Readership Study is a national survey of magazine reading and other media use in a sample carefully designed to over-represent consumers suffering from specific ailments. The over-sampling is done to obtain statistically reliable data for the small population groups important to Direct-to-consumer drug advertising. In the fusion, individual respondent records from MARS are joined to the individual respondent records of the Nielsen Peoplemeter panel based upon characteristics the respondents have in common. The links include age, sex, a number of household variables, geography, cable/non-cable and volume of TV viewing. The resulting fused MARS/NTI database reports national estimates of magazine reading and TV viewing among the sufferers of specific ailments as if they were collected by a single-source survey using the Nielsen Peoplemeter to measure TV and the MARS frequency-of-reading questionnaire to measure Print. User-match versus Demo-match
Up to now the industry has focused on the value of fusion in estimating cross-media duplication for media-mix reach planning and optimization. An equally important use of fusion is in targeting television. TV planning and buying have always relied upon simple demo matching to target potential buyers. This takes the prominent user age/sex demographic as reported by User Survey A and selects programs attracting viewers in that demo from TV Survey B .The problem with this approach is age/sex targets seldom define consumer markets. More often they just show concentration of buyers. This results in "targeting error" of two kinds. Many in the demo target will not be product users (false positives) and many users of a product will not be in the demo target (false negatives).
Furthermore it is likely that adding some other combination of factors like marital status, lifestyle, geography, and income would help to better predict the ailment. That's what fusion provides. Fusing MARS with NTI allows agencies to select TV networks, genres and programs, based upon the ascribed viewing of acid reflux sufferers rather than the simple age/sex demographic tendency of that sufferer group. This in theory can produce a major improvement in TV planning and buying. Different Buying Decisions
Moving from theory to practice, it seems to work. Since the MARS records are fused to NTI, the TV planning and buying currency at the respondent level, it is possible to run optimized schedules using the fused database to compare the cost consequences of using the demo target instead of the ailment. Here are the different solutions the Kantar X*Pert TV optimizer produces. The targets compared are Acid Reflux Sufferers and Adults 35+ (Table 1). TABLE 1
X*pert TV Optimization. Adults 35+ versus Acid Reflux Sufferers 65 Reach Goal.
X*Pert shows a 65 reach of Adults 35+ requires 146 target points. The fused database shows that schedule generates 153 GRP's against Acid Reflux Sufferers and delivers a 67 reach. The higher numbers signal that targeting the demo results in buying too much television. To reach 65 percent of Acid Reflux Sufferers requires only 143 target points distributed differently. This reduces the cost of a 65 reach from $3,227,699 to $2,816,094, a saving of 13 percent. So in this case it seems possible to buy a TV reach goal for less by using the ailment in place of the demographic. Sinus Sufferers
Another example. This comparison is between Adult Sinus Headache Sufferers and Adults 18-49, the corresponding demo target (Table 2). TABLE 2
X*pert TV Optimization. Adults 18-to-49 Versus Sinus Headache Sufferers 65 Reach Goal.
X*Pert shows a 65 reach of Adults 18-49 requires 166 target points. But this is overkill for Sinus Sufferers. The fused database shows it generates 190 Sinus Sufferer GRP's, many more than needed which takes the plan above the 65 reach goal to a 70. To reach 65% of Sinus Sufferers requires only 150 target points distributed differently. This costs $2,959,056 instead of the original $3,880,229 or 24% less than the original plan. Both examples suggest it is possible to buy TV target reach for less using fused ailment data in place of demographics. The open question is "why does this happen?" Should we be convinced by these results? Some ailments increase TV viewing
I think the fusion is sound enough to use for planning in these cases because MARS internal data show ailments like Acid Reflux and Sinus Headache correlate with viewing levels higher than those of the surrogate age demos (Adults 35+ and Adults 18-49). And the MARS/NTI fusion uses volume of viewing as a linking variable.
The same pattern holds for a large number of ailments like backache, depression,
insomnia and obesity, where the sufferer is perhaps less active than
his or her demo counterpart because of the ailment itself (Table 3).
TABLE 3
TV Viewing Rates Ailment versus TV Planning Demo
Targeting Error is the issue The usual question "how good is a fusion?" is the wrong question. We should be asking "is using the fusion better than what we are currently doing?" The yardstick "better" and the problem of "Targeting error" are key to understanding the value of fusion. As the Acid Reflux and Sinus examples make clear, in cases where TV viewing is increased by the ailment, the benefits of fusion seem pretty obvious. They make the considerable point that age/sex targeting may waste a lot of DTC dollars. [3] One suspects that tighter targeting through fusion could help a wider range of advertised products. Especially those where use correlates with more or less TV viewing. Conclusion
Many planners, including the author, have been skeptical of the value of planning TV based on usage data because television does not target user groups very well. But it now seems obvious that where usage correlates with TV viewing, the value of user targeting can be enormous.
[1] Today's TV/Print fusions are limited by the absence of readership data in the TV database, but TV viewing data is usually collected in both. [2] There is no way to reduce demo-targeting error. A more inclusive demo includes more people who are not in the target, and a narrower demo excludes more people who are the target. [3] There will certainly be cases where the user
group views less than the surrogate demo and requires more dollars than the
plan assumes. - September 10, 2002 -
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||